✦ LIBER ✦

Weekly docetaxel as first-line therapy for elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Hainsworth, J.D; Burris, H.A; Morrissey, L.H; Litchy, S; Greco, F.A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

P-500 Weekly docetaxel and vinorelbine a

✍ Huber, R.; Schmidt, M.; Borgmeier, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Weekly docetaxel as second line chemothe

✍ M. Serke; D. Argiropolus; N. Schönfeld; R. Loddenkemper 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Weekly docetaxel vs. docetaxel-based com

✍ Gebbia, Vittorio; Gridelli, Cesare; Verusio, Claudio; Frontini, Luciano; Aitini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB

794 Weekly paclitaxel (W-PAC) as second-

✍ G.L. Ceresoli; V. Gregorc; S. Cordio; K. Bencardino; A. Spreafico; C. Cozzarini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Results of a phase II multicenter trial

✍ Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB